Angiology
Bare-metal stent restenosis rates are lower in an unselected patient population
Published in Medical Devices and Surgical Technology Week, October 8th, 2006
"Randomized trials have shown that DES substantially reduce in-stent restenosis compared with BMS. Revascularization event rates related to BMS restenosis may be higher in the trials setting than in real-world experience, calling into question the extent of benefit possible with widespread DES use in regular practice. Between December 1998 and March 2003, 17,102 patients with BMS registered in the Goodroe Healthcare Solutions Data Warehouse...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Anesthesia
Myocardial protection during CABG surgery may be provided by volatile anesthetic agents - Angiology
Protected carotid stenting in high-surgical-risk patients is safe and effective - Drug Delivery
Mitomycin C incorporated into P(HEMA) hydrogels inhibits cell proliferation - Ophthalmology
Retinal blood flow can be redirected in vivo through borosilicate micro-cannulas - Adenoid Cystic Cancer
Sex cord tumor with annular tubules diagnosed by fine needle aspiration - Adipose Tissue
Whole-body T1 mapping improves the definition of adipose tissue - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
